Odiel Jean-Baptiste
Family Medicine · Palm Springs, FLNPI 1881938819
Payments from drug & device makers
Across 527 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$3K
- Johnson & Johnson$934
- Janssen Products, LP$549
- Theratechnologies Inc.$516
- Merck$391
- plus $2K from 22 others
What the payments were for
- Food & beverage$10,53798%
- Education$2282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 179 | $3,773 |
| Gilead | 161 | $2,970 |
| Johnson & Johnson(2 entities) | 62 | $934 |
| Janssen Products, LP | 6 | $549 |
| Theratechnologies Inc. | 17 | $516 |
| Merck | 18 | $391 |
| AbbVie | 15 | $274 |
| Indivior Inc. | 11 | $267 |
| EMD Serono, Inc. | 11 | $211 |
| Napo Pharmaceuticals Inc | 7 | $142 |
| Amgen | 6 | $107 |
| Lilly USA, LLC | 5 | $89 |
| AstraZeneca | 5 | $81 |
| Neurocrine Biosciences, Inc. | 2 | $60 |
| Orexo US, Inc. | 4 | $59 |
| Braeburn Inc. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $50 |
| Almatica Pharma LLC | 2 | $35 |
| Smith+Nephew | 1 | $32 |
| GSK | 2 | $30 |
| Boehringer Ingelheim | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Evoke Pharma, Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,765 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 85 | $351,897 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 64 | $253,502 |
| DovatoDolutegravir Sodium/Lamivudine | 42 | $135,544 |
| TivicayDolutegravir Sodium | 50 | $123,685 |
| PrezcobixDarunavir/Cobicistat | 50 | $121,507 |
| DescovyEmtricitabine/Tenofov Alafenam | 27 | $59,105 |
| IsentressRaltegravir Potassium | 18 | $35,364 |
| JanuviaSitagliptin Phosphate | 15 | $17,286 |
| JardianceEmpagliflozin | 14 | $12,543 |
| OzempicSemaglutide | 12 | $10,929 |
| Emtricitabine | 13 | $10,427 |
| EliquisApixaban | 15 | $8,423 |
| Sucralfate | 18 | $4,538 |
| Atorvastatin Calcium | 96 | $947 |
| Nifedipine ErNifedipine | 36 | $748 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $2,970 | $664,504176 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $3,773 | $259,22992 claims |
| Johnson & JohnsonPrezcobix | $934 | $121,50750 claims |
| MerckIsentress, Januvia | $391 | $52,65033 claims |
| Boehringer IngelheimJardiance | $22 | $12,54314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Palm Springs
- Luis CastilloPalm Springs$6M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.